|
Re: Apabetalone downregulates factors and pathways associated with vascular calcification
|
3
|
Resverlogix Corp.
|
Nov 20, 2018 10:53AM
|
|
Interesting read while we wait for eGFR news
|
3
|
Resverlogix Corp.
|
Mar 17, 2020 06:51AM
|
|
Re: ASN late breaker and CKD sub-study top-line
|
3
|
Resverlogix Corp.
|
Oct 09, 2019 08:22PM
|
|
eGFR data question from IR
|
3
|
Resverlogix Corp.
|
Nov 26, 2019 12:30AM
|
|
Re: Q4 2019 Events
|
3
|
Resverlogix Corp.
|
Oct 07, 2019 04:18PM
|
|
Re: Did another Seeking Alpha Instablog post...
|
3
|
Resverlogix Corp.
|
Dec 03, 2018 11:12AM
|
|
Biogen's drug article,...
|
3
|
Resverlogix Corp.
|
Dec 05, 2019 02:08AM
|
|
Re: Biotech Showcase Presentation is up
|
3
|
Resverlogix Corp.
|
Jan 07, 2019 08:11PM
|
|
MOA of Apabetalone - only affects sick patients
|
3
|
Resverlogix Corp.
|
Apr 15, 2019 07:57AM
|
|
Re: AHA Late Breaker!
|
3
|
Resverlogix Corp.
|
Sep 20, 2019 12:07PM
|
|
Re: Breakthrough Therapy Designation Application
|
3
|
Resverlogix Corp.
|
Dec 06, 2019 09:59AM
|
|
Re: Just checked the chart again....seeing another wedge
|
3
|
Resverlogix Corp.
|
Apr 04, 2019 12:10PM
|
|
Re: Dr. Kausik Ray on BETonMACE
|
3
|
Resverlogix Corp.
|
Dec 07, 2019 05:27PM
|
|
Re: What population would our CD drug cover,...?
|
3
|
Resverlogix Corp.
|
Nov 27, 2019 02:17PM
|
|
5 point MACE
|
3
|
Resverlogix Corp.
|
Mar 22, 2019 07:40AM
|
|
Re: Can someone tell me why this news today is not NR worthy?
|
3
|
Resverlogix Corp.
|
Dec 06, 2019 10:06AM
|
|
Re: Third Eye, AHA, US Listing
|
3
|
Resverlogix Corp.
|
Sep 19, 2019 08:07AM
|
|
Re: eGFR.....
|
3
|
Resverlogix Corp.
|
Feb 07, 2020 10:32AM
|
|
Re: Biotech Showcase Presentation is up
|
3
|
Resverlogix Corp.
|
Jan 07, 2019 10:45PM
|
|
Re: Vacepa new
|
3
|
Resverlogix Corp.
|
Mar 19, 2019 04:01PM
|
